IJ
Innovative Health Initiative Joint Undertaking (IHI JU)

Per- and Poly-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector

Funds one project to map, replace, reduce and safely dispose of PFAS chemicals used in medicines, vaccines, devices and diagnostics.

At least 45% of the whole consortium's contribution has to come from industry, and every proposal has to include a compulsory 'Declaration of in-kind contribution commitment' annex spelling out what industry partners are putting in beyond cash. The two stages use different templates: the short first-stage proposal uses its own Part B template plus a compulsory 'Type of Participants' annex, while t

This topic wants a mapping of where PFAS chemicals sit in the healthcare supply chain, a database of alternatives, and new PFAS disposal processes — with the ultimate aim of replacing PFAS in medical technology without compromising patient safety. Where replacement isn't yet feasible, it wants better exposure control and standardised testing instead.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.€33.8M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
IJ
Open

An AI Foundation Toxicology Model and Framework to Support Waiving a Second Species in Drug Safety Studies

🇨🇦IHI JU · European Union

Funds development of an AI toxicology model that lets drug developers waive costly second-species animal safety testing.

MedtechAI
€9MOct'26
IJ
Open

Decode the Immunoscience of age-related diseases

🇪🇺IHI JU · European Union

Funds a research consortium that studies why immune-mediated diseases behave differently when they first strike older adults and hunts for biomarkers to predict them.

BiotechMedtech
€9.2MOct'26
IJ
Open

IHI European HealthCare Incubator Network

🇨🇦IHI JU · European Union

Funds a pan-European industry-and-academia incubator network that re-grants up to EUR 2,000,000 each to early-stage healthcare startups.

MedtechBiotech
€35MOct'26
IJ
Closed

AI-Powered Signal Detection in Pharmacovigilance

🇪🇺IHI JU · European Union

Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.

MedtechAI
€8.9M
IJ
Closed

Boosting innovation for a better understanding of the determinants of health

🇪🇺IHI JU · European Union

Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.

Medtech
€8M – €30M
IJ
Closed

Boosting innovation for better assessment of the added value of innovative integrated healthcare solutions

🇪🇺IHI JU · European Union

Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.

Medtech
€5M – €9.8M